Viewpoint: Expanding TRIPS waiver is bad for innovation
December 15, 2022 at 11:59 AM EST
The World Trade Organization is considering expanding the TRIPS waiver to the new Covid-19 treatments and diagnostics. This would undercut American innovation, writes the CEO of Anthos Therapeutics.
